Health
Sionna’s Cystic Fibrosis Drug Fails Mid-Stage Trial
Sionna Therapeutics' experimental cystic fibrosis pill failed to show added benefits when combined with Vertex's Trikafta, disappointing investors and the biotech industry.
Coverage timeline — 1 article
STAT News
A pill from Sionna Therapeutics provided no added benefit when combined with Vertex's cystic fibrosis blockbuster Trikafta, a blow to the biotech.
2026-08-10 12:03 UTC